The Latest Breaking News from GOVX

With the Fed’s meeting hot on the heels of an estimate-beating inflation figure, the market has braced itself for an aggressive interest rate hike. This spells trouble for beaten-down penny stocks whose underlying businesses look set to remain starved of funds required to keep them going. Thus, given their bleak…

On Modnay, shares of GeoVax Labs, Inc. (NASDAQ: GOVX) experienced volatile short activity. After the activity, the stock price went up +66.91% to $2.32. The overall sentiment for GOVX has been Bearish.

The U.S. Patent and Trademark Office has issued Patent No. 11,311,612 covering GeoVax Labs Inc's (NASDAQ:GOVX) modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. GeoVax's MVA-VLP malaria vaccine candidates incorporate antigens derived from multiple stages of the parasite's life cycle. They are designed to induce an immune response with durable…